Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Net Cash Flow: 2017-2025

Historic Net Cash Flow for Arcus Biosciences (RCUS) over the last 9 years, with Sep 2025 value amounting to -$10.0 million.

  • Arcus Biosciences' Net Cash Flow fell 122.22% to -$10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.0 million, marking a year-over-year increase of 117.65%. This contributed to the annual value of $23.0 million for FY2024, which is 129.11% up from last year.
  • Latest data reveals that Arcus Biosciences reported Net Cash Flow of -$10.0 million as of Q3 2025, which was down 117.86% from $56.0 million recorded in Q2 2025.
  • In the past 5 years, Arcus Biosciences' Net Cash Flow registered a high of $401.0 million during Q1 2022, and its lowest value of -$276.0 million during Q2 2022.
  • For the 3-year period, Arcus Biosciences' Net Cash Flow averaged around $2.9 million, with its median value being -$8.0 million (2023).
  • In the last 5 years, Arcus Biosciences' Net Cash Flow skyrocketed by 2,228.58% in 2021 and then slumped by 375.00% in 2023.
  • Quarterly analysis of 5 years shows Arcus Biosciences' Net Cash Flow stood at -$31.8 million in 2021, then skyrocketed by 62.29% to -$12.0 million in 2022, then tumbled by 375.00% to -$57.0 million in 2023, then rose by 10.53% to -$51.0 million in 2024, then slumped by 122.22% to -$10.0 million in 2025.
  • Its last three reported values are -$10.0 million in Q3 2025, $56.0 million for Q2 2025, and $42.0 million during Q1 2025.